Business:
EpiPens' price jumped more than 500%, and lawmakers want to know why

Lawmakers are demanding more information on why the price for lifesaving EpiPens has skyrocketed.

EpiPens are used to ward off potentially fatal allergic reactions, and their price has surged in recent years. A two-dose package cost less than $60 nine years ago. The cost is now closer to $400.

Sen. Charles Grassley (R-Iowa) wrote to Mylan, the company that manufactures the devices, and asked for more information on why the prices have increased. He cited the cost to parents whose children need them and also to schools that keep the EpiPens on hand. The school costs are passed on to taxpayers, he said.

Rep. Grace Meng (D-N.Y.) asked the House Oversight and Government Reform Committee on Tuesday to hold a hearing on the issue. She is a co-chair of the Congressional Kids Safety Caucus.

“Thousands of Americans rely on EpiPens in a given year, and perhaps no time is more important in the purchasing of these devices than the beginning of a new school year,” she wrote in a letter to the committee chairman, Jason Chaffetz (R-Utah).

90 seconds: 4 stories you can't miss Caption 90 seconds: 4 stories you can't miss

Clinton continues to face heat over emails, Hearst Castle threatened by fire, an illness hits Skid Row, and ex-L.A. Coliseum official Todd DeStefano's corruption case sentencing.

Clinton continues to face heat over emails, Hearst Castle threatened by fire, an illness hits Skid Row, and ex-L.A. Coliseum official Todd DeStefano's corruption case sentencing.

Pfizer to buy Medivation for $14 billion Caption Pfizer to buy Medivation for $14 billion

Pharmaceutical giant Pfizer Inc. announced a $14-billion deal to purchase Medivation Inc. on Monday.

Pharmaceutical giant Pfizer Inc. announced a $14-billion deal to purchase Medivation Inc. on Monday.

A two-dose package has been selling for more than $365 recently, according to data from Elsevier Clinical Solutions' Gold Standard Drug Database. 

ALSO

Why having a food allergy costs more for the poorest kids

Column: Here's why it's so difficult to solve soaring drug prices

As a drug pricing transparency bill stumbles in Sacramento, the battle turns to November's ballot

Source:   latimes
Source Link:   latimes

Misafir Avatar
Name
Submit Comment
Characters Left:
Your comment has been forwarded to the administrator for approval.×

Ashley Furniture slashes production in Inland...
The company says the majority of production at the site east of Los Angeles is going to other U.S. plants to create...

Read News